| Hepatocellular carcinoma: an overview of the changing landscape of treatment options A Koulouris, C Tsagkaris, V Spyrou, E Pappa, A Troullinou, M Nikolaou Journal of hepatocellular carcinoma, 387-401, 2021 | 83 | 2021 |
| Resistance to TKIs in EGFR-mutated non-small cell lung cancer: from mechanisms to new therapeutic strategies A Koulouris, C Tsagkaris, AC Corriero, G Metro, G Mountzios Cancers 14 (14), 3337, 2022 | 26 | 2022 |
| Real impact of novel immunotherapy drugs in cancer. The experience of 10 last years A Koulouris, C Tsagkaris, M Nikolaou Toxins 13 (2), 149, 2021 | 10 | 2021 |
| The changing epidemiology of hepatocellular carcinoma in Greece GE Markakis, A Koulouris, M Tampaki, E Cholongitas, M Deutsch, ... Annals of gastroenterology 35 (1), 88, 2022 | 6 | 2022 |
| Resectable colorectal cancer: current perceptions on the correlation of recurrence risk, microbiota and detection of genetic mutations in liquid biopsies A Koulouris, C Tsagkaris, I Messaritakis, N Gouvas, M Sfakianaki, ... Cancers 13 (14), 3522, 2021 | 5 | 2021 |
| Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis G Tsakonas, S Ekman, A Koulouris, H Adderley, CJ Ackermann, ... International Journal of Cancer 153 (9), 1556-1567, 2023 | 4 | 2023 |
| Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities C Tsagkaris, N Trygonis, V Spyrou, A Koulouris Cancers 15 (14), 3700, 2023 | 4 | 2023 |
| The fractal viewpoint of tumors and nanoparticles A Alexiou, C Tsagkaris, S Chatzichronis, A Koulouris, I Haranas, ... Current Medicinal Chemistry 30 (3), 356-370, 2023 | 3 | 2023 |
| Matched analyses of brain metastases versus primary non-small cell lung cancer reveal a unique microRNA signature G Tsakonas, A Koulouris, D Kazmierczak, J Botling, C Ortiz-Villalon, ... International journal of molecular sciences 24 (1), 193, 2022 | 3 | 2022 |
| Brain and bone marrow metastases from rectal cancer K Thomopoulou, S Manolakou, I Messaritakis, M Tzardi, E Lagoudaki, ... Annals of Gastroenterology 33 (1), 95, 2020 | 2 | 2020 |
| Immunotherapy for the treatment of metastatic small cell lung cancer: Focus on pembrolizumab A Koulouris, G Mountzios Expert Review of Clinical Pharmacology 14 (6), 651-659, 2021 | 1 | 2021 |
| Carnitine modulates crucial myocardial adenosine triphosphatases and acetylcholinesterase enzyme activities in choline-deprived rats AA Strilakou, ST Tsakiris, KG Kalafatakis, AT Stylianaki, PL Karkalousos, ... Canadian Journal of Physiology and Pharmacology 92 (1), 78-84, 2014 | 1 | 2014 |
| Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis I Messaritakis, A Koulouris, E Boukla, K Vogiatzoglou, I Lagkouvardos, ... Cancers 16 (10), 1923, 2024 | | 2024 |
| Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases I Zerdes, C Kamali, A Koulouris, M Elsayed, J Schnorbach, ... ESMO open 8 (6), 102069, 2023 | | 2023 |
| EP12. 01-18 Validation of the ALK-Brain Prognostic Index (ALK-BPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases G Tsakonas, C Kamali, I Zerdes, A Koulouris, P Hydbring, P Christopoulos Journal of Thoracic Oncology 18 (11), S647, 2023 | | 2023 |
| EP11. 03-40 An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients M Skribek, A Sierakowiak, A Koulouris, K Rounis, J Goenechea, M Labor, ... Journal of Thoracic Oncology 18 (11), S638, 2023 | | 2023 |
| P-158 Comprehensive recurrence risk assessment after colectomy, for stage II and III colorectal cancer patients, using genetic profiling, microbiome, and circulating tumor markers I Messaritakis, M Sfakianaki, A Koulouris, M Chondrozoumaki, ... Annals of Oncology 33, S306, 2022 | | 2022 |
| Detection of microbial DNA in the blood of colorectal cancer patients for the diagnosis of microbial translocation. I Sougklakos, I Messaritakis, K Vogiatzoglou, K Tsantaki, A Dretaki, ... Journal of Clinical Oncology 38 (4_suppl), 171-171, 2020 | | 2020 |
| The Stereotactic Radiosurgery-Brain Prognostic Index (SRS-BPI): A Novel Prognostic Index for Lung Cancer Patients with Brain Metastases Eligible for SRS A Koulouris, M Skribek, C Kamali, O Grundberg, M Gubanski, K Kalaitzidis, ... Available at SSRN 4862658, 0 | | |
| Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy A Koulouris, C Tsagkaris, G Mountzios Forum of Clinical Oncology, 0 | | |
Christos TsagkarisUniversity of Crete, Faculty of Medicine在 edu.med.uoc.gr 的电子邮件经过验证
